000			02146 a2200553 4500
005			20250514034800.0
264		0	_c20020918
008			200209s 0 0 eng d
022			_a0934-9723
024	7		_a10.1007/s10096-002-0723-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchürmann, D
245	0	0	_aEffectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. _h[electronic resource]
260			_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cMay 2002
300			_a353-61 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAIDS-Related Opportunistic Infections _xcomplications
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnimals
650	0	4	_aAnti-Infective Agents _xtherapeutic use
650	0	4	_aAntiretroviral Therapy, Highly Active
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Combinations
650	0	4	_aFemale
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHumans
650	0	4	_aLeucovorin _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPneumocystis _xdrug effects
650	0	4	_aPneumonia, Pneumocystis _xcomplications
650	0	4	_aPyrimethamine _xadministration & dosage
650	0	4	_aSulfadoxine _xadministration & dosage
650	0	4	_aToxoplasma _xdrug effects
650	0	4	_aToxoplasmosis, Cerebral _xcomplications
700	1		_aBergmann, F
700	1		_aAlbrecht, H
700	1		_aPadberg, J
700	1		_aWünsche, T
700	1		_aGrünewald, T
700	1		_aSchürmann, M
700	1		_aGrobusch, M
700	1		_aVallée, M
700	1		_aRuf, B
700	1		_aSuttorp, N
773	0		_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 21 _gno. 5 _gp. 353-61
856	4	0	_uhttps://doi.org/10.1007/s10096-002-0723-3 _zAvailable from publisher's website
999			_c11967950 _d11967950